Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00474708
Status:
COMPLETED
Last Update Posted:
2012-03-05
First Post:
2007-05-10
Brief Title:
Study Comparing the Efficacy of Venlafaxine XR Vs SSRIs and Conventional Antidepressants in Depressed Patients
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
The Efficacy of Venlafaxine XR Efexor XR Versus SSRIs Conventional Antidepressants in Depressed Patients Switched From Prior Antidepressants in Psychiatric Outpatient Care Settings in China
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an open-label randomized multi-center study conducted in a typical psychiatric outpatient practice in China This study is intended to collect data on the efficacy and safety of venlafaxine XR Efexor XR versus SSRIs and conventional antidepressants in depressed patients that previously failed antidepressant treatment This data will be used to guide psychiatrists on recommendations for clinic use
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None